Insider buying last 90 days
No open-market insider purchases were filed for DLB in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Dolby Laboratories closed at $64.79 on 9 November 2026, -0.1% on the day. The price sits above both the 50-day ($60.77) and 200-day ($59.34) moving averages, inside a 52-week range of $48.26 to $69.95. The GekkoIndex reads 46.8, in the Neutral zone, down 4.6 points over five sessions. Gekko Fair Value is $72.43, so the price is 10.5% below it.
The next earnings report is due on 17 November 2026, 2 days away (after close). Over the last 8 reports the company beat the earnings estimate 7 times, with an average move of 7.5% across the report. Seasonally, the next 20 trading days from this point averaged +4% over the last 5 years, rising in 4 of them.
2 firms rate the stock: 2 buy, 0 hold and 0 sell, with a consensus target of $79.00. A typical daily move is about 2.6%, and a typical 20-day move about 4.2%. On the swing-trade checklist, 3 items read supportive and 1 reads as a headwind (earnings risk).
A plain summary of the figures as of the Nov 9, 2026 close.
Dolby Laboratories scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $63.61 is above the 50-day ($60.99) and 200-day ($59.38) averages, and the 50-day is above the 200-day.
See the chart51.7, Neutral
Reading 51.7 is in the Neutral zone.
See the GekkoIndex10.7% below
Price is 10.7% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 2 days
Reports on Nov 17, 2026, 2 days away — inside a typical 20-trading-day hold.
See earnings+3.4% on average
From this point in the calendar, the next 20 trading days averaged +3.4% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Dolby Laboratories closed at $63.61 on Nov 13, 2026, −4.8% over the past year, inside a 52-week range of $48.26 to $69.95.
Use the left and right arrow keys to read daily values.
Put DLB on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Dolby Laboratories creates audio and imaging technologies used to improve sound and picture quality across entertainment and communication systems, spanning movie theaters, television broadcasts, streaming platforms, mobile devices and home entertainment setups. It is widely recognized for its audio and video coding formats, including AAC, AVC, Dolby AC-4, Dolby Atmos, Dolby Digital and its variants, Dolby TrueHD, HEVC, and imaging and voice technologies such as Dolby Vision and Dolby Voice, which together shape how sound and visuals are delivered on many types of playback equipment.
The company generates revenue partly by licensing these technologies to other manufacturers and media platforms, while also designing and building physical products such as cinema servers, processors, amplifiers, loudspeakers and video conferencing equipment. It provides supporting services for theatrical and television production, covering exhibition, broadcast operations and home entertainment needs. Its customer base includes film studios, content creators, post-production houses, cinema operators, broadcasters and video game developers, reached both directly and through a worldwide network of dealers and distributors.
Dolby Laboratories was founded in 1965 and is headquartered in San Francisco, California. Its shares are listed on the NYSE under the ticker DLB.
Dolby Laboratories’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.7, in the Neutral zone, up 6 points over five sessions.
Up 6 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 38 | +0.7% | +2.6% | ||
| Accumulation | 311 | +0.1% | +1.4% | ||
| Neutral (current zone) | 340 | −0.4% | −2.9% | ||
| Distribution | 12 | +0.4% | −0.6% | ||
| Selling | 1 | Too few readings yet | |||
Average DLB share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Dolby Laboratories trades 10.7% below Gekko Fair Value of $71.23, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Dolby Laboratories shares are worth, recalculated every trading day.
$71.23
Gekko Fair Value, Nov 14, 2026
10.7% Undervalued
At the end of Aug 2026 the price was 15.0% below the estimate.
No open-market insider purchases were filed for Dolby Laboratories, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for DLB in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in DLB were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Dolby Laboratories has been buying back its own shares.
From company filings.
Dolby Laboratories reports on Nov 17, 2026, after the close (2 days away), and beat the EPS estimate in 7 of its last 8 reports.
Nov 17, 2026
Expected after the close, 2 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.43 est $0.40 | $305.0M est $312.0M | +11.9% |
| Apr 30, 2026 | $0.00 est $1.34 | $395.6M est $385.8M | −9.2% |
| Jan 29, 2026 | $1.06 est $0.99 | $346.7M est $341.3M | +4.9% |
| Nov 18, 2025 | $0.99 est $0.70 | $307.0M est $305.8M | +0.7% |
| Jul 31, 2025 | $0.78 est $0.71 | $315.5M est $305.8M | −7.4% |
| May 1, 2025 | $1.34 est $1.27 | $369.6M est $305.2M | −2.5% |
| Jan 29, 2025 | $1.14 est $0.98 | $357.0M est $383.8M | +8.3% |
| Nov 19, 2024 | $0.81 est $0.70 | $304.8M est $307.9M | +14.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Dolby Laboratories is $79.00, +24.2% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 19 | Barrington | $90 | +41.5% |
| Aug 27 | William Blair | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Dolby Laboratories averaged +3.4% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.2% | 2 of 5 |
| Next 10 trading days | +0.5% | 3 of 5 |
| Next 15 trading days | +2.8% | 3 of 5 |
| Next 20 trading days | +3.4% | 4 of 5 |
| Next 30 trading days | +2.0% | 2 of 5 |
For scale, DLB’s typical 20-trading-day move in either direction is about 4.2%.
Dolby Laboratories’s market cap is $5.96B, with a P/E ratio of 27.5 and revenue of $1.35B over the last twelve months.
1 headline about Dolby Laboratories from the past week, newest first, each linking to the publisher.
Dolby Laboratories’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 10.6% above |
| PLTRPalantir Technologies | Accumulation | 8.2% below |
| ORCLOracle | Neutral | 27.9% below |
| PANWPalo Alto Networks | Accumulation | 0.6% above |
| CRWDCrowdStrike | Accumulation | 0.9% above |
| CRMSalesforce | Accumulation | 12.1% below |
A peer links to its own page where one exists.
Dolby Laboratories’s market cap is $5.96B at the Nov 13, 2026 close of $63.61, with 59.42M shares outstanding. The shares trade on a P/E ratio of 27.5.
The consensus analyst 12-month price target for Dolby Laboratories is $79.00, +24.2% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Dolby Laboratories is undervalued: the Nov 13, 2026 close of $63.61 is 10.7% below Gekko Fair Value of $71.23. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Dolby Laboratories is expected to report on Nov 17, 2026, after the market closes (2 days away). Analysts expect earnings of $1.19 per share on revenue of $372.8M. Dolby Laboratories beat the earnings estimate in 7 of its last 8 reports, moving 7.5% on average across the report.
Dolby Laboratories’s 52-week high is $69.95 and its 52-week low is $48.26; it closed at $63.61 on Nov 13, 2026, −4.8% over the past year. Over the last five years the shares peaked at $96.85 on Jan 3, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.